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ABSTRACT 
Throughout embryonic development, blood vessels are derived from endothelial cells by 
way of vasculogenesis. During angiogenesis, vessels remodel to form a hierarchy of 
large-diameter arteries that branch into small-diameter capillaries. In this maturation, 
vessels respond to unidentified signaling events to become surrounded with an outer layer 
of vascular smooth muscle cells (vSMCs). This results in arteries that have a thick vSMC 
layer, veins that have a thin vSMC layer, and capillaries that have a very thin or absent 
vSMC layer. What remains to be determined is the cause of the thicker layer of vSMCs 
around proximal arteries. Previous studies have implicated that mechanical forces 
provided by blood flow control the growth of arteries over capillaries. I hypothesize that 
these mechanical forces also determine the extent of vSMC coverage. To test this, I 
compared the extent of vSMC in arteries of normal-flow mouse embryos (wild type) with 
those in reduced-flow embryos (Myl7 [-/-] mutant). I observed less vSMC coverage in the 
proximal arteries from reduced-flow embryos versus normal-flow embryos. With 
immunostaining and confocal imaging, I determined that the amount of vSMCs did not 
differ between reduced-flow and normal-flow tissues. Reduced-flow tissues exhibit a 
failure of the vSMCs to migrate away from capillaries towards proximal arteries, and a 
failure to surround the arteries. My findings provide evidence that hemodynamic force is 
required for vSMC recruitment, but not for vSMC differentiation or proliferation. 
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INTRODUCTION 
 
 The cardiovascular system is comprised of a heart and blood vessels, and it is the 
first functional organ system formed during embryonic development in mammals (Moore 
and Metcalf, 1970), In the very early mammalian embryo, the cardiovascular system is 
not required, as the embryo is small enough to rely upon simple molecular diffusion from 
the surrounding maternal fluids/tissues. However, as the embryo grows, a functional 
cardiovascular system is vital for the exchange of nutrients, gases, and waste products. 
To set up this system, the embryo has the challenge of creating a hierarchical, branched 
blood vessel tree, with large vessels connected to the heart, which connect to smaller 
vessels far away from the heart. This is an important physiological adaptation for proper 
oxygen exchange and for the efficient movement of blood. The establishment of this 
complex vascular pattern is regulated by a series of cues that promote blood vessel 
growth and development by several mechanisms: vasculogenesis, angiogenesis, 
artery/vein specification, and vascular maturation.  
 
Vasculogenesis 
Vasculogenesis is the de novo development of new vessels from an aggregation of 
endothelial cell precursors (angioblasts). Though the first blood vessels form during 
vasculogenesis, this process can occur at various stages throughout an organism’s life. 
Before vasculogenesis can occur, mesoderm tissue must form first, ultimately allowing 
for angioblasts to emerge from a subset of the mesoderm. The mesoderm originates 
during gastrulation when the primitive streak forms and elongates, and differentiating 
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mesoderm cells ingress between the epiblast and primitive endoderm layers in a process 
called epithelial-to-mesenchymal transition (EMT). This occurs at E6.0-6.5 (Embryonic 
day—7 days after fertilization) in mice (Ichikawa et al., 2013). Upon EMT, epiblast cells 
downregulate epithelial genes, such as E-cadherin, and upregulate other genes that gives 
them the ability to migrate. Subsequently, they acquire mesenchymal markers such as N-
cadherin (Ferrer-Vaquer et al., 2014). As cells from the epiblast migrate into the embryo, 
all three germ layers of the mouse embryonic and extraembryonic tissue are present: 
endoderm, mesoderm (embryonic and extraembryonic), and ectoderm (Kovacic et al., 
2012). 
Vasculogenesis first starts in an extraembryonic tissue, called the yolk sac, where 
blood vessels arise from a subset of extraembryonic mesoderm to give rise to primitive 
yolk sac vessels E7.0 (Drake and Fleming 2000). Here, hemangioblasts 
(blood/endothelial multipotent progenitor cells) arise from a subset of the extraembryonic 
mesoderm. These cells collect together to form a structure called the “blood islands”. 
Hemangioblasts of the blood islands then begin to differentiate into angioblasts 
(endothelial cell precursors) and hematopoietic cells (blood cell precursors). Immediately 
after, the angioblasts form tubes to encapsulate the hematopoietic cells, and these tubes 
connect with other tubes to create the primitive capillary plexus of the yolk sac (Moore 
and Metcalf, 1970) (Schmidt et al., 2007). The capillary plexus is a network of primitive 
blood vessels that do not have any obvious hierarchies, as the capillaries are all 
interconnected and have similar diameters. The formation of the capillary plexus relies 
heavily on the activations of the Vascular Endothelial Growth Factor (VEGF) signaling 
pathway (Ferguson et al., 2005). VEGF acts to regulate endothelial cell differentiation, 
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migration, proliferation, and blood vessel branching patterns. Ultimately, VEGF 
activation leads to the further differentiation of angioblasts into endothelial cells that now 
express other endothelial markers (Pecam1, Tek, Laminin and Tal).  
Slightly later (E7.3), the dorsal aortae (paired embryonic blood vessels) forms 
from the connection of embryonic mesoderm-derived angioblasts to form a pair of 
vessels that extend from the heart towards the posterior tail of the developing embryo 
(Drake and Fleming, 2000). In the early embryo (E7.3), blood cell production exclusively 
occurs in the yolk sac. By E7.8-E8.0, the yolk vessels connect to the heart, and the heart 
connects to the dorsal aorta, and this connects back to the yolk sac vessels; thus forming a 
circulatory loop. 
 
Angiogenesis overview 
 The formation of new blood vessels from preexisting vessels is called 
angiogenesis. This is accomplished through several different mechanisms, which also 
leads to the development of blood vessel hierarchy. Angiogenesis occurs not only in 
development, but during wound healing, hypoxia of tissues, and tumor growth in adult 
tissues (D'Alessio et al., 2015). 
 During mouse development, angiogenesis begins at E8.5 in the newly formed 
capillary plexus. Blood vessel formation occurs via four different mechanisms: sprouting, 
fusion, intussusception, and regression. Sprouting is the most common mechanism used 
during angiogenesis as well as in in adult tissues. A vessel can sprout from a pre-existing 
vessel by a signal (VEGF) from the surrounding tissue. Specifically, an endothelial cell 
of a blood vessel that is exposed to the highest amount of VEGF will become an 
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endothelial tip cell. Tip cells are capable of growing/sprouting out of the vessel. Specified 
tip cells then communicate to adjacent endothelial cells of the blood vessel via Dll4 
(Delta like ligand 4)-induced Notch signaling. This provides two functions: 1) to 
proliferate and provide more stalk cells behind the tip cells to grow out the sprout, and 2) 
to downregulate the Vegf receptor so that the stalk cells do not become tip cells 
themselves (D'Alessio et al., 2015). Another angiogenesis mechanism is blood vessel 
fusion. Newly formed vessels will fuse to neighboring vessels. This can be done between 
two parallel vessels to create a larger vessel (Udan et al., 2013a), and it could be done at 
the tip of vessels to connect vessel sprouts together. It is known that macrophages aid in 
blood vessel fusion by secreting VEGF-C to induce tip cell fusion (Tammela et al., 
2011). Regression is the pruning of blood vessels to eliminate supernumerary vessels, and 
to refine vessel branching patterns. Notch/Dll4 signaling has also been shown to play an 
important role in vessel regression (Korn and Augustin, 2015). The last known 
mechanism of angiogenesis is intussusception, which is the angle change of blood 
vessels. This form of angiogenesis is the least common, but has been detected in rodent 
lung capillaries, and in chicken chorioallantoic vessels (Kurz et al., 2003). 
Intussusception involves the formation of an endothelial pillar through the middle of a 
vessel, and the expansion of that pillar, changing the angling of the vessel (Herbert and 
Stainier, 2011). 
 
Angiogenesis: vascular remodeling 
All four mechanisms of angiogenesis play an important role in building new 
vessels from preexisting vessels, but also in patterning the new vessels to create 
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hierarchies and unique branching patterns. This later concept is named vascular 
remodeling, which primarily acts by regulating vessels diameters to create the hierarchy. 
Thus, vascular remodeling contributes to the formation of large-diameter arterial vessels, 
which carry blood away from the heart, and large-diameter venous vessels, which carry 
blood back towards the heart.    
Hemodynamic force regulates vascular remodeling. For a decade, it has been 
known that hemodynamic force (force that blood flow exerts on a blood vessel) acts as a 
signal to promote the remodeling of the vasculature. For example, loss-of-function of the 
Myosin light chain 7 (Myl7) gene, also known as Myosin light chain 2 (Mlc2a), 
specifically impairs the ability of the atria of the heart to contract, leaving only the left 
and right ventricles to pump blood (Huang et al., 2003). This produces a reduced blood-
flow mouse embryo model (called reduced-flow) that results in a lack of vascular 
remodeling (even though vessels do not express Myl7). Studies have confirmed that this 
defect in remodeling was due to a lowering of hemodynamic force because experimental 
removal of blood cells from circulation, in cultured embryos, lowers fluid viscosity. This 
also reduces hemodynamic force, resulting in a lack of vascular remodeling (Lucitti et al., 
2007). However, if these same embryos are injected with hetastarch to increase plasma 
viscosity, the vascular remodeling phenotype is recused, providing evidence that 
hemodynamic force regulates remodeling. Moreover, subsequent studies have confirmed 
that vessels exposed to high hemodynamic force undergo vessel-diameter increase by the 
fusion of neighboring vessels together; whereas, vessels exposed to low hemodynamic 
force remain as small-diameter capillaries (Lucitti et al., 2007); (Udan et al., 2013a). In 
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summary, it is clear that hemodynamic forces play a crucial role in the development of 
vessels. 
Artery/venous specification. There are certain molecular markers that specify 
endothelial cells to become endothelial vein or endothelial artery cells, but this varies by 
location. In the mouse yolk sac plexus, EphrinB2 is involved in the determination of 
arterial endothelial cells; whereas, EphB4 is involved in the determination of venous 
endothelial cells (Shin et al., 2001). Also, Notch signaling (Delta-like ligand 4 and 
Jagged2) helps specify arterial endothelial cells; whereas venous endothelial cells are 
controlled by CoupTFII (You et al., 2005). In the intraembryonic tissue, artery and vein 
genes are present but at different time points. Efnb2 and Notch related genes (Hey1, 
Hey2, Dll4, Notch1 and Notch4) are expressed first in artery-fated endothelial cells and 
then venous-fated endothelial cells (Corada et al., 2014). 
Though arterial and venous markers become expressed prior to the onset of flow, 
other evidence suggests that flow plays an important role in the maintenance of 
arterial/venous gene expression. In chick embryos, the expression of EphrinB2 (arterial 
marker) is dependent on flow and is not activated without the presence of blood flow (le 
Noble et al., 2004). In the murine model, Neurophilin1 (Nrp1) plays a vital role in 
capillary plexus patterning, but loss of flow downregulated EphrinB2, which is also 
impacted by loss of Nrp1 (Jones et al., 2008).  
 
Blood vessel maturation 
Blood vessel maturation occurs after vessels remodel. This process occurs to 
create a stable, mature vessel through the recruitment of mural cells to the recently 
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remodeled endothelium layer. The term mural cell refers to both vascular smooth muscle 
cells (vSMCs) and pericytes (Gaengel et al., 2009). Vascular smooth muscle cells 
collectively wrap around large vessels as a tissue layer; whereas, pericytes are individual 
cells that wrap around single capillaries.  
In adults, vascular smooth muscle cells form a tissue layer called the tunica 
media, which functions to regulate contractile tone, and hence blood flow in adult 
vessels. The tunica media thickness varies in different tissues, which is dependent on the 
function of that tissue. The arteries contain a very thick tunica media that helps to 
counteract the strong pressure of oxygenated blood that is pumped throughout the entire 
body. Veins contain the second thickest tunica media because the pressure of the 
deoxygenated blood is reduced. However, capillaries have only a one-cell thick 
endothelium, occasionally covered by single pericytes, or no tunica media at all (West, 
2000). The reason for the reduction in vSMCs in capillaries is to enhance tissue 
oxygenation. Lessons learned about embryonic vSMCs can likely still apply to adult 
vSMCs because these cells are quite plastic and can detach from vessel walls, undergo 
proliferation and migration, and reattach/redifferentiate into a stable form. This plasticity, 
called phenotypic modulation, can occur in adult vessels upon injury, disease or growth 
of new vessels (Jacot and Wong, 2008). 
Since developing vessels are initially devoid of mural cells, understanding mural 
cell origin may provide insight into their subsequent coverage of the endothelium. Mural 
cells (vSMCs and pericytes) differentiate from various embryonic and extraembryonic 
tissues, such as the neural crest, lateral plate mesoderm, and somatic/paraxial mesoderm 
(Armulik et al., 2011). The main transcription factor that is required for the 
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differentiation of mural cells from these tissues is serum response factor (SRF). However, 
SRF is expressed ubiquitously throughout all cells during development, so there must be 
other mechanisms to precisely control which cells become mural cells (Barron et al., 
2005). Factors that may provide tissue-specificity of mural cell differentiation are the 
transcriptional coactivators of SRF: Myocardin, MRTF-A, and MRTF-B. These cofactors 
are also required for vSMC differentiation, as loss of these genes in mice leads to in a 
failure of vSMCs to differentiate, and overexpression of these cofactors in non-vSMCs 
results in the induction of vSMC markers (Mack et al,. 2011). Myocardin, MRTF-A and 
MRTF-B may allow SRF to function in a tissue-specific manner in a subset of mesoderm 
and neural crest cells because MRTF-A and MRTF-B are highly expressed in vSMCs, 
and Myocardin is detectable in vessels. 
In the early yolk sac, when vessels are being remodeled (between E8.5 and 
E9.25), the tissue is completely devoid of vSMCs, and by E9.5 the vSMCs arise from the 
mesoderm, and quickly begin to surround the vessels. It is unclear how genes such as 
Mrtf-A, Mrtf-B and Myocardin become upregulated in a subset of this mesoderm. Studies 
have implicated Notch2, Notch3, Pdgf-β, and Tgf-β to act upstream of the transcriptional 
coactivators to control their differentiation (Mack et al. 2011). However, whether these 
same factors control vSMC coverage around vessels is unclear, because in addition to 
controlling vSMC differentiation, they have also been shown to regulate vSMC 
proliferation and recruitment. Therefore, it is unclear exactly how these factors influence 
the cellular behaviors of vSMCs during the maturation process. Thus, more studies need 
to be done to elucidate the role that vSMC differentiation, proliferation, or recruitment 
play in vessel maturation.   
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Even if Notch2, Notch3, Pdgf-B and Tgf-B regulate vascular coverage, it is 
challenging to understand why only the large proximal vessels are capable of having the 
highest vSMC coverage. Previous studies have implicated that every capillary of the yolk 
sac that receives high-hemodynamic force is capable of forming the large proximal 
vessel. This lends itself to the idea that hemodynamic force is also required for 
determining the extent of vSMC coverage during maturation. Insight into the role of 
hemodynamic force in regulating vSMC coverage may have important implications for 
human health and disease, as there are many diseases associated with the thinning of 
vessel walls. 
 
Human significance 
 Improper thickness of vessel walls can lead to a variety of health problems in 
humans, from a bulging of vessels known as a hemangioma or birthmark to congenital 
brain aneurysms. Congenital vascular malformations (CVMs) occur in roughly 1% of all 
live births in the United States and can affect arteries, veins, and lymphatic vessels in 
children (Eerola et al., 2003). CVMs have many different forms of presentation, all with 
varying impacts on health, which ranges to nearly unnoticeable to life threatening. 
Arteriovenous fistula (or shunting) is the abnormal connection between veins and arteries 
that can lead to swollen veins and arteries, decreased diastolic pressure, and an increased 
burden on cardiac output (Liberthson et al., 1979). Children can be born with this 
condition in a variety of places throughout their body, from the thoracic cavity to limbs. 
Despite the frequent occurrence of these conditions, as of now, there is no explanation for 
these phenomena (Jabari et al., 2016). 
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 Congenital arteriovenous aneurysms are rare but deadly when they occur in the 
brain. Between 1939 and 2011, roughly 1200 cases of non-traumatic pediatric brain 
aneurysms were reported (Sorteberg and Dahlberg, 2013). The causes of the aneurysms 
are unknown, and many are unrelated to any disease. Hemorrhaging of the thinning 
vessels usually occurs several years after birth. Many children have giant aneurysm 
events when compared to adults, and their hemorrhaging events repeat throughout their 
lifetime (van Rooij and Sluzewski, 2009). It has been reported that the mortality rate of 
children with hemorrhaging events is as high as 50%. Follow-up studies and studies 
discussing neurological functionality after an event are sparse due to many of the patients 
in the initial study dying before completion of follow-up exaninations (Kakarla et al., 
2010). 
 Because of the variety of congenital vascular malformations and the reduced 
lifespan of children born with them, it is important to understand the causes of these 
CVMs. Many causes of CVMs are unknown and thus, treatments are reactive rather than 
preventative. Development of treatments could include a drug to thicken vessel walls to 
prevent repeated hemorrhaging events in congenital aneurysms patients. 
 
Hypothesis and goals  
My study begins to investigate whether hemodynamic force impacts the maturation of 
blood vessels by affecting the coverage of vSMCs around large proximal vessels. As 
previously stated, mouse embryos subjected to low hemodynamic force display impaired 
vascular remodeling (Lucitti et al., 2007). In these embryos, proximal vessels fail to 
undergo an expansion in diameter that is normally found at the top of the vessel 
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hierarchy. In our preliminary studies, I sought to assess whether hemodynamic force 
similarly affects vSMC coverage during maturation. I found that proximal arteries and 
veins exhibited a high and medium level of vSMC coverage, respectively. This correlated 
to differences in flow regimes in proximal arteries and veins, as previously published 
(Udan et al., 2013b). Further, I also determined that reduction of hemodynamic force 
resulted in diminished vSMC coverage in proximal vessels, resulting in a coverage 
observed similar to that in distal capillaries of normal-flow embryos.  Thus, 
hemodynamic force must be controlling vSMC coverage, but the cellular mechanism for 
this loss of coverage is unknown. I proposed two hypotheses to explain this loss of 
coverage upon reduced hemodynamic force:   
1. Hypothesis one: Hemodynamic force promotes the localized proliferation and/or 
differentiation signals of vSMCs.  
In this hypothesis, hemodynamic force may affect the number of vSMCs by 
promoting the localized proliferation or differentiation of vSMCs around vessels 
of high-flow. Here localized proliferation/differentiation would be followed by 
immediate adhesion around the nearby vessels without much vSMC migration 
(Fig. 1).  
2. Hypothesis two: Hemodynamic force promotes the recruitment of vascular 
smooth muscle cells.  
In this hypothesis, hemodynamic force does not regulate the number of vSMCs. 
Instead, it regulates the recruitment of vSMCs towards areas of high 
hemodynamic force (Fig. 2).  
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MATERIALS AND METHODS 
 
Mouse care and lines 
 This study used animal subjects and prior approval for this project was obtained 
from the Missouri State University Institutional Animal Care and Use Committee 
(November 20, 2014; approval #15-004.0-A, December 01, 2014; approval #15-008.0-
A). Housing and procedures involving the mice met the requirements of National 
Institute of Health animal care and use guidelines. Adult Myl7/Mlc2a (referred to as Myl7 
in this study) (Huang et al., 2003) and Myl7;CD1-Tg(sma-mCherry) (Armstrong et al., 
2010) mice were bred in the animal vivarium. All mice were housed in Ancare standard 
mouse cages at a temperature of 20.0-23.0 °C and under a diurnal cycle of 12-h light/ 12-
h dark, and had ad libitum access to water and Purina Labdiet 5001 (Purina) when not in 
experimental use or Purina Formulab diet 5008 (Purina) when used for breeding and 
experiments. Female and male mice used for experiments ranged 2-to-12 months in age. 
 Myl7/Mlc2a (Huang et al., 2003) and Myl7;CD1-Tg(sma-mCherry) (Armstrong et 
al., 2010) embryos were used for immunohistochemistry whole yolk sac experiments. 
Myl7 embryos and yolk sacs were used for flow cytometry experiments. Myl7;CD1-
Tg(sma-mCherry) embryos and yolk sacs were used for whole yolk sac 
immunohistochemistry experiments. Determination of embryonic day was measured after 
a noticeable vaginal plug present in the afternoon, marking that time point as E0.5. 
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Whole yolk sac immunohistochemistry 
Adult pregnant mice were euthanized in a plastic container via CO2 inhalation 
followed by cervical dislocation. Whole embryos were isolated at E10.5 in cold 
Phosphate Buffer Saline (PBS). The uterine muscle and decidua were removed to expose 
the intact yolk sac. A small hole was cut into the top of the ectoplacental cone to ensure 
exchange of buffer in and out of the yolk sac. 
Embryos were fixed in 4% paraformaldehyde (PFA) in polypropylene round-
bottom tubes while rotating on a nutator for 35 minutes. Embryos were washed 3 times 
for 5-10 minutes each using PBS while shaking at room temperature. Then, the embryos 
were given a final 5-10 minute wash using PBS containing 0.1% Triton (PBT) while 
shaking at room temperature. Embryos were then washed in blocking buffer of 5% 
Normal Donkey Serum (NDS; Sigma D9663-10mL), 1% Bovine Serum Albumin (GE 
Healthcare Life Science SH30574.01) (BSA), in PBT for 1.5 hours at 4° C while shaking. 
Embryos were then incubated for 48 hours in primary antibody with Serum Buffer Triton 
(2.5% NDS in PBT) (SBT). 
Primary antibodies used for these experiments and what they label are listed in 
Table 1. Embryos were then washed several times in SBT over the course of one day to 
be incubated in secondary antibody in SBT for 48 hours at 4° C while shaking. The 
secondary antibodies used for these experiments and what they label are listed in Table 1. 
Embryos were then washed in SBT 4 times by shaking at 4° C for 20 minutes, and the 
last wash was done with PBS. The yolk sac was dissected open to display the arterial tree 
on the right and venous vein on the left, and was mounted onto plain 3” x 1” x 1 mm 
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microscope slides (Fisher Scientific 12-544-1). Slides were then imaged using confocal 
microscopy. The embryos were saved for genotyping. 
 
Quantification of vSMC total number and vSMC undergoing mitosis 
 Myl7;CD1-Tg(sma-mCherry) yolk sacs from E10.5 embryos were isolated, 
stained with PH3 antibody or Kdr antibody and Sma antibody, and yolk sacs were flat 
mounted on plain slides. Confocal images of endothelial, vascular smooth muscle, or 
mitotic cells were taken using Olympus IX81-ZDC inverted fluorescence microscope 
with the Slidebook 6.0 software. For area analysis of vSMCs in the distal capillary 
regions, 5 Myl7 (+/+) & (-/-) yolk sacs and 4 Myl7 (-/-) yolk sacs were imaged. For area 
analysis of mitotic cells and vSMC total, 7 Myl7 (+/+) & (+/-) yolk sacs were imaged and 
4 Myl7 (-/-) yolk sacs were imaged. A random sample of 10 images (10 slices at 2.2 µm 
for each image) were taken across different regions of each yolk sac using spinning disc 
confocal EM-CCD digital camera, and a projection of the Z-stack was made to produce a 
single image. 
Quantification of the amount of vSMCs present in capillary regions of the yolk 
sac was not possible because cell boundaries were not apparent. As a result, two or more 
cells that overlap may appear as one cell. Thus, to quantify the amount of vSMCs that 
occupy capillary regions, the percent area occupied by vSMCs divided by total surface 
area was determined in reduced-flow yolk sac samples Myl7(-/-) and normal-flow yolk 
sac samples Myl7(+/-).  This was done by binarizing the image using Adobe Photoshop 
so that all vSMCs were black and the background tissue was white. The percent area that 
the vSMCs occupied was measured using ImageJ. Statistical analysis was done using a 
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Student’s t-test in Microsoft Excel. For quantification of vSMC undergoing mitosis, PH3, 
Sma double positive cells were quantified. These can be quantified as single cells, as the 
PH3 labeling is distinct and does not overlap with other PH3-stained nuclei. These values 
were then divided by the percent area occupied by the total vSMCs to give an estimate of 
the amount of mitotic vSMCs in reduced-flow and normal-flow yolk sacs.  
 
Flow cytometry/quantification of total cells and vSMCs 
Total cell count and total vSMC count was analyzed using flow cytometry of 
Myl7 (-/-) and Myl7 (+/-) embryo or yolk sac tissue. Whole embryos with yolk sacs were 
isolated in cold Hank’s balanced salt solution with calcium chloride and magnesium 
chloride (HBSS+) (Fisher Scientific) at E10.5 and the uterine muscle and decidua were 
discarded. Both mutant and wild-type tissues were used and kept in 300 µL HBSS+, 
separated based on phenotype. The embryos were separated from the yolk sac and saved 
for analysis, the tails were cut to be used for genotyping. The tissue types used in this 
experiment are listed in Table 2. 
Cells were centrifuged at 300g for 30 seconds then media was replaced with Type 
II 0.2% collagenase (Thermo Fisher Scientific, #17101015). Degradation of collagen was 
done by incubating cells in 37°C incubator and by sequential pipetting with a pipette tips 
of decreasing size (1000 µL, 200 µL, 10 µL) and finally with a 25 G x 38mm hypodermic 
needle (Fisher Scientific, #14-826-49). Cells were filtered using a 40 µm cell strainer 
(Fisherbrand), centrifuged at 300g for 10 minutes, after the removal of the medium and 
fixed in 100 µL 2% PFA for 5-20 minutes (depending on experiment) on ice. Cells were 
centrifuged at 300g for 10 minutes, media removed, then incubated in 100 µL 1x 
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Permwash (Biolegend) and 2.5% NDS for 10 minutes on ice. Then, cells were 
centrifuged at 300g for 10 minutes, after the removal of the medium, the cell pellet was 
resuspended in 100 µL 1x Permwash (with or without 1:200 SmaCy3 antibody), and 
incubated for 15 minutes at room temperature. For flow cytometry analysis, cells were 
centrifuged at 300g for 10 minutes then placed in 100 µL 1x Permwash and quantified in 
a BD Accuri C6 Flow Cytometer. Samples were run through on unlimited events, for a 
maximum of 1,000,000 events that included forward side scatter over 10,000. 
Parameters on the C6 software were chosen based on repeated trials of control 
autofluorescence yolk sacs and embryos without the Sma-Cy3 antibody as compared to 
fluorescence of samples with the Sma-Cy3 antibody. This allowed for comparison of the 
cells natural fluorescence with the fluorescence that occurs upon addition of the Sma-Cy3 
antibody. Cells with background fluorescence were removed from counts by selecting the 
forward scatter gate of registering events that fluoresce at 104 or higher. 
 
Tail cuts/DNA isolation 
 Juvenile and adult mice had tail cuts performed for genotyping. Juvenile tail cuts 
were performed without anesthesia and used for DNA isolation. Adult mouse tail cuts 
were performed with 3ppm isoflurane until mice were unconscious, then tails were 
clipped. 200 µL of tail buffer (1 mL of 5M NaCl, 2.5 mL of 1M Tris pH 8.0, 10 mL of 
0.5M EDTA pH8.0, 5 mL of 10% SDS, q.s. 50 mL) was added to the tail clip with 10 µL 
Proteinase K (Thermo Scientific) and incubated for 24 hours at 55°C. The solution was 
briefly mixed by flicking the tube to finalize resuspended tissue and 200 µL of phenol 
chloroform was added. The tubes were then gently mixed by shaking up and down 20-30 
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times and centrifuged for 10 minutes at 13.3 g at room temperature. Subsequently, the 
aqueous phase was transferred to a clean microcentrifuge tube, and the organic phase was 
discarded. An equal amount of 100% isopropanol was added, mixed, and then 
centrifuged at 13.3g for 10 mins. The solution was removed by decanting, the pellet was 
washed in 500 µL of 70% ethanol, and centrifuged at 13.3 g for 10 minutes. The ethanol 
was decanted and the tubes were left to dry upside down on a tissue. The DNA was 
suspended in 75 µL of distilled water was 24 hours at 4°C. 
 
PCR genotyping 
DNA extracted from embryonic tails were used for genotyping to validate 
phenotypic expression. Purified embryonic DNA was amplified using Pro-Taq DNA 
polymerase (Deville Scientific, Inc) and the following primers (5’ – 3’): wild-type band, 
Myl7-wt-F (GGCACGATCACTC) and Myl7-wt-R (ATCCCTGTTCTGG); mutant band, 
Myl7-mut-F (ACAGGGAATCACA) and Myl7-mut-R (CGAACCTGGTCGA). PCR 
cycles consisted of denaturing at 95.0°C for 5 minutes, then 35 cycles of denaturing at 
95.0°C 30 seconds, annealing at 56.5°C 30 seconds, and extension at 72.0°C 1 minutes, 
and a final extension at 72.0°C for 5 minutes. 
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Table 1. Antibodies used in my study. 
Antibody Experimental 
Procedure 
Dilution Company Incubation 
Period 
Anti-vascular 
endothelial 
growth receptor 
2, made in goat 
Whole Yolk 
Sac (both) 
1:200 Abcam 48 hours 
Anti-alpha 
smooth muscle 
actin-Cy3, 
made in mouse  
Whole Yolk 
Sac (both), 
Flow 
Cytometry 
1:1250, 1:250 Sigma Sciences 48 hours 
Anti-histone 
H3, made in 
rabbit 
Whole Yolk 
Sac (Mitosis  
count) 
1:500 Abcam 
 
24 hours 
DAPI, made in 
mouse 
Whole Yolk 
Sac (vSMC 
count) 
1:500 Sigma Sciences 48 hours 
Alexa Fluor 
488 donkey 
anti-goat 
Whole Yolk 
Sac (vSMC 
count) 
1:500 Life 
Technologies 
48 hours 
Alexa 568 
donkey anti-
rabbit 
Whole Yolk 
Sac (mitosis 
count) 
1:500 Life 
Technologies 
24 hours 
Alexa Fluor 
488 donkey 
anti-rabbit 
Whole Yolk 
Sac (mitosis 
count) 
1:500 Life 
Technologies 
48 hours 
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Table 2. Tissues used in quantification of total cells and vSCMs 
 
Tissue Type Amount Genotype Antibody 
Embryo 1 Wild-type None 
Yolk Sac 2 Wild-type None 
Embryo 1 Mutant None 
Yolk Sac 2 Mutant None 
Embryo 1 Wild-type Anti-alpha smooth 
muscle actin-Cy3 
Yolk Sac 2 Wild-type Anti-alpha smooth 
muscle actin-Cy3 
Embryo 1 Mutant Anti-alpha smooth 
muscle actin-Cy3 
Yolk Sac 2 Mutant Anti-alpha smooth 
muscle actin-Cy3 
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PRELIMINARY DATA 
 
vSMC coverage is reduced in yolk sac vein and capillaries compared to artery 
As mentioned above, adult blood vessels exhibit a difference in vSMC coverage 
between arteries, veins, and capillaries, with arteries having highest vSMC coverage. 
Since I are interested in understanding what controls vSMC coverage, I sought to 
determine if the same difference in thickness is apparent during embryonic development. 
Yolk sacs from E10.5 embryos were used, as the vasculature is well developed and 
vessels have matured. For example, the arterial tree exhibits regular branching into 
smaller primary and secondary branches; the vitelline vein displays two main vessels; and 
the capillary region connects the arteries and veins. These vessels have already initiated 
maturation only one day earlier (at E9.5), and by E10.5 stable, mature blood vessels have 
formed. 
To observe if there was a vSMC coverage difference between yolk sac arteries, 
veins, and capillaries, whole-mount immunostaining and confocal microscopy was used. 
The proximal artery showed complete vSMC coverage around the inner lining of the 
vessel— comprised of endothelial cells (Fig. 3A-C). In comparison, the vein showed 
vSMC coverage around the vessel, however, the fluorescence signal was not as strong as 
in the artery (Fig. 3D-F). Also, vSMC coverage was the most dramatically reduced in the 
capillary region of the mouse yolk sac (Fig. 3G-I). These data reveal that the extent of 
vSMC coverage is similar to what is observed in the adult, even at this very early stage of 
maturation.  
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Interestingly, the amount of vSMC coverage correlated to the levels of 
hemodynamic force, as previously measured in proximal arteries, veins, and capillaries of 
yolk sacs (Udan et al. 2013). Considering that hemodynamic force has been shown to 
regulate vessel hierarchy, I sought to determine if hemodynamic force is similarly 
required for controlling the amount of vSMC coverage. 
 
Vascular smooth muscle layer is reduced with low hemodynamic force in the yolk 
sac proximal artery and the dorsal aorta 
 To determine whether hemodynamic force impacts the maturation of blood 
vessels, I analyzed vSMC coverage in Myl7 reduced-flow mutant (-/-) and normal-flow 
control (+/-) embryonic yolk sacs. The yolk sac vasculature in normal-flow arteries 
displayed a large diameter vessel comprised of endothelial cells and a complete coverage 
of vSMCs (Fig. 4A-C). However, the proximal artery of the yolk sac in reduced-flow 
embryos showed poor vessel development, and minimal vSMC coverage of the vessel 
(Fig. 4D-F).  
Next, I sought to determine if this phenotype was similarly found in 
intraembryonic vessels. Though the capillary network is still growing in E10.5, the most 
prominent vessel of the embryo, the dorsal aorta, is functional. The challenge to imaging 
these vessels is that it is internal, thus, it could not be imaged by a whole-mount 
approach, due to light scattering issues, thus, I performed cross sections. E10.5 normal-
flow dorsal aorta cross sections showed robust vessel development of the endothelial 
cells and complete vSMC coverage around the vessel (Fig. 4G-I). Similar as the reduced-
flow yolk sac vasculature, the reduced-flow dorsal aorta also exhibited reduced vessel 
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development and almost no vSMC coverage around the vessel (Fig. 4J-L). These results 
reveal that reduction of hemodynamic force does not impact blood vessel formation, but 
does impact its maturation. 
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RESULTS 
 
Low Hemodynamic Force does not impact the Proliferation and Differentiation of 
vSMCs 
It is clearly evident that hemodynamic force regulates that amount of vSMCs that 
surround the yolk sac and embryonic arteries, and I similarly saw this disparity in 
reduced-flow proximal veins (data not shown). To explain this phenotype, two 
hypotheses were formulated: 1) hemodynamic force regulates the localized 
proliferation/differentiation of vSMCs (which later surround the closest vessels), 2) 
hemodynamic force regulates the recruitment of vSMCs to the high-flow, proximal 
vessels (without affect the differentiation/proliferation status of the cells) (Fig. 1). 
To determine whether vSMC proliferation was influenced by reduction of 
hemodynamic force, I stained normal-flow and reduced-flow yolk sac tissue with a 
mitotic antibody marker (phospho-Histone H3 [PH3]) and co-labeled with a vSMC 
antibody marker (Smooth muscle alpha actin [Sma]). PH3 cells were easily identified and 
counted: however, vSMCs could be visualized, this was a cytoplasmic marker. It was 
difficult to determine whether two vSMCs that were adhered together where separate 
cells or the same cell. Thus, I quantified total PH3-labeled cells and divide this number 
by the total surface area occupied by vSMC staining to determine a mitotic index. After 
comparing the mitotic index in normal-flow vs. reduced-flow embryonic yolk sacs, I 
observed no difference in proliferation—suggesting that hemodynamic force does not 
affect the proliferation status of vSMCs (Fig. 5I). 
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 Though this data indicates that hemodynamic force does not impact global levels 
of proliferation, perhaps it affects the ability for vSMCs to differentiate. One strategy to 
determine whether there is an altered differentiation status is to assess changes in vSMC 
differentiation markers. Thus, I sought to determine if expression of the vSMC 
differentiation marker, Mkl2 (Mokalled et al., 2015), was altered upon reduced-flow. 
However, qRT-PCR of Mkl2 in normal-flow versus reduced flow E10.5 yolk sacs 
revealed no significant difference in global expression patterns of Mkl2 (data not shown). 
One caveat to this experiment is that there could be minute differences in gene expression 
that are not detectable by qRT-PCR, but perhaps reduced-flow yolk sacs still exhibit 
diminished vSMC differentiation. In this case, flow could still impact the total number of 
vSMCs available to cover vessels. 
 
Hemodynamic force does not impact the total number of vSMCs available 
Since there could still be undetectable differences in vSMC differentiation, this 
could affect the total amount of vSMCs available to cover vessels, even if the vSMC 
proliferation rates are the same. For example, if one tissue starts off with 8 vSMCs, and 
another with 10 vSMCs, if all parent and daughter cells divide three times, the first tissue 
will have ~ 512 vSMCs, and the second would have 1000 vSMCs—nearly double the 
amount. Thus, I wanted to determine if reduced-flow embryos and yolk sacs have a lower 
total amount of vSMCs than in normal-flow yolk sacs. Using microscopy, it is impossible 
to visually quantify the total number of vSMCs because of the overlap around proximal 
arteries and veins. Thus, to measure if there was a total change of vSMC affected by low 
hemodynamic force, flow cytometry with the Sma antibody was used (Fig. 1). 
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Measurements were taken by counting the total number of vSMCs (Sma+ cells) divided 
by the total number of embryo or yolk sac cells that flow through the cytometer. This 
allows for accurate comparisons between tissues that may not be the exact same size. 
Normal-flow and reduced-flow tissue from whole embryos were compared and no 
significant difference in the amount of vSMCs was observed (Fig, 6). Similarly, no 
significant difference in the total amount of vSMCs was found when comparing yolk sac 
tissue (Fig. 6). In summary, hemodynamic force does not impact the total number of 
vSMCs available for vessel coverage. I reasoned, therefore, that a factor other than 
hemodynamic force explain why reduced-flow vessels fail to acquire a vSMC layer.  
 
Hemodynamic force affects the recruitment of vSMCs from capillary region to 
proximal vessels 
Based on my observations that hemodynamic force did not impact the total 
number of vSMCs available, I speculated that hemodynamic force did not affect the 
ability for vSMCs to differentiate from the mesoderm, or to exhibited altered 
proliferation. Instead, vSMCs failed to be recruited from the surrounding capillary region 
towards the proximal arteries and veins (Fig. 2). To assess if recruitment is impaired by 
reduced-flow, Myl7;CD1-Tg(sma-mCherry) with Sma-myr::mCherry transgenic mouse 
yolk sac were used to assess an area analysis of the space occupied by vSMC in the 
capillary regions. The premise behind this analysis is that in normal-flow yolks sacs, 
vSMCs differentiate and proliferate normally in the capillary regions, and they migrate 
towards the larger, high-flow proximal vessels. In reduced-flow, on the other hand, I 
speculate that the cells do not migrate to the proximal vessels (because they have low-
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flow). As a result, I anticipate visualizing more vSMCs in the capillary regions of 
reduced-flow yolk sacs.   
Capillary regions of normal-flow yolk sacs showed that there were vSMCs 
present (Fig. 7A-D). However, in the capillary regions of reduced-flow yolk sacs, there 
was an increase in the amount of vSMCs present (Fig. 7E-H). After binarization and area 
analysis, there was a significant increase in the amount of area occupied by vSMCs in 
low hemodynamic force capillary regions relative to the normal flow capillary regions 
(Fig. 7I). Thus, this suggests that hemodynamic force promotes the recruitment of 
vSMCs to vessels of high-flow. 
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DISCUSSION 
 
 Adult vessels that are located closer to the heart (proximally) have a thicker tunica 
media layer relative to vessels closer to the extremities (distally) (Isayama et al., 2013). 
Vessels closer to the heart are subjective to much stronger hemodynamic forces and must 
have a thicker vascular smooth muscle layer to counteract those forces. Data produced by 
this study supports that differences in tunica media thickness are established during 
embryonic development, and that hemodynamic force is the key regulator for vSMC 
coverage. Results demonstrate that the cellular mechanism of hemodynamic force-
induced vascular maturation involves the recruitment of vSMCs from the capillary 
regions towards the proximal arteries and veins, and this does not occur by a localized 
vSMC proliferation/differentiation mechanism. 
 In normal-flow mouse embryos, our results revealed noticeable differences in 
vSMC coverage in different vessel subtypes, with highest coverage in proximal arteries, 
followed by a progressively reduced coverage in proximal veins and capillaries. This 
reduction is likely due to the differences during development in the amount of 
hemodynamic force that the developing vessels are exposed to. For example, proximal 
arteries in the mouse yolk sac are subjected to the strongest forces, as blood leaving the 
embryo enters into the yolk sac (McGrath et al., 2003); (Udan et al., 2013). Upon the 
distribution of the blood into numerous capillaries, hemodynamic force diminishes. As 
blood collects in the proximal vein is carried blood away from the yolk sac back to the 
embryonic heart, the hemodynamic force increases but will not the level found in 
proximal arteries. These differences in force correlate well with differences in vSMC 
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coverage, implicating that extent of hemodynamic force determines the amount of vSMC 
coverage. Indeed, hemodynamic force is required for proper maturation, as our data in 
reduced-flow embryos reveals diminished or an absent vSMC coverage, even around 
proximal arteries.  
Given the correlation of the amount of force and the extent of vSMC coverage, I 
propose a model where hemodynamic force acts like an analog signal, rather than a 
digital signal. Thus, force induces a gradient of recruitment signaling of vSMCs, as 
oppose to an on-and-off signaling mechanism. The wide variety in thickness of tunica 
media lends support to this model. There is no set amount of thickness for a given vessel 
and there is a variation throughout an organism (Dinardo et al., 2014). 
A recently published study reached a similar conclusion, and proposed that 
hemodynamic force regulated mural cell coverage in blood vessels (Chen et al., 2017). 
Using zebrafish embryos, the Santoro lab proposed a mechanism where blood vessel 
endothelial cells possess non-motile cilia that deflect upon exposure to hemodynamic 
force. This, in turn upregulates Notch and Foxc1b expression to encourage mural cell 
recruitment. Based on evidence that our lab and others have collected, it appears as if 
there is partial conservation of this pathway in the mouse. What is not conserved is the 
role of non-motile cilia. These cilia are not detected in mouse yolk sac vessels (personal 
communication with Mary Dickinson, Baylor College of Medicine). What does appear to 
be conserved is the Notch pathway, which I have observed is downregulated in reduced-
flow mouse embryos (data not shown). However, more studies need to be done to 
validate the role of Notch in vSMC recruitment, and to determine the role of the FoxC1 
gene in vascular maturation of the mouse. Though the Santoro lab has provided insight 
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into the molecular mechanisms of vSMC coverage, the investigators did not assess 
whether increased coverage occurs via vSMC recruitment or localized vSMC 
proliferation/differentiation. 
The mechanism of how high-flow, proximal vessels signal the recruitment of 
vSMCs remains unknown. One possible mechanism is that high-flow vessels recruit 
vSMCs via chemotaxis towards a paracrine factor. For example, vessels that are exposed 
to high hemodynamic force could induce Notch activation. This, in turn, could upregulate 
expression of a paracrine factor, and vSMCs will migrate in the direction towards the 
highest concentration of the paracrine factor. In another possible mechanism, maturation 
occurs via a juxtacrine pathway. Perhaps, vSMCs randomly migrate throughout the yolk 
sac, but they only adhere to vessels that express adhesion factors, like cadherins or gap 
junction molecules. In this scenario, vSMCs only adhere to high-flow vessels which 
express a high amount of adhesion molecules.  
To determine which mechanism occurs, live imaging and cell tracking studies will 
be performed. However, it is challenging to visualize vSMC recruitment over time in 
mice. vSMCs differentiate at around E9.5, and the culturing mouse embryos beyond this 
point is challenging. Thus, in future studies, confocal imaging will be performed using 
E9.5 embryos that will be cultured only for several hours (instead of overnight). Though 
several problems need to be overcome (setting up the confocal for live embryo culture, 
determining whether excitation light will allow for visualization but will not 
photodamage the embryo, and ensuring that the culturing time is sufficient to visualize 
migration), the ultimate goal will be to visualize if vSMCs stream towards proximal 
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vessels, or if they undergo random migration, but stick to the proximal vessel when 
nearby.  
Though the studies of this thesis represent basic science, my findings could have 
significant applicability for human health and medicine. By ultimately discovering the 
mechanism for vSMC recruitment, this information could be used to control vSMC 
recruitment in adult vessels that are depleted of the tunica media (perhaps caused by a 
congenital defect, injury, or environmental factors). For example, aneurysms are regions 
of a blood vessel that have a weak vessel wall, partly caused by the degradation of the 
tunica media that are prone to ballooning and potentially hemorrhaging. Currently, stents 
are used to repair cardiovascular aneurysms, however, many patients experience repeated 
aneurysm events, leading to a reduced lifespan (Lederle et al., 2012). Since stents can be 
used to deliver localized treatment by seeding with a drug (Giap, 2002), stents could be 
seeded with discovered factors to encourage vSMCs to be recruited to the thin vessel 
walls. It is possible that adult vSMCs will respond in a way similar to the embryonic 
vSMCs response, because they are capable of reverting to an embryonic-like vSMC (a 
process called phenotypic modulation) where they are capable of partial dedifferentiation, 
proliferation, migration, and redifferentiation (Rensen et al., 2007). In summary, results 
from my basic science research could point in the direction of possible clinical advances.  
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Figure 1. Hypothesis 1: Hemodynamic force promotes the localized proliferation and/or 
differentiation of vSMCs. In normal-flow yolk sacs, areas of high hemodynamic force, 
including the proximal arteries and veins, secrete differentiation and/or proliferation 
signals to promote the localized differentiation and/or proliferation of vSMCs; whereas, 
the distal capillaries with low hemodynamic force would have fewer vSMCs. In this 
model, vSMCs are limited in the ability to migrate around the yolk sac, so they wrap 
around the nearest vessels, resulting in a higher amount in proximal vessels. If 
hemodynamic force is reduced throughout the entire yolk sac, the expected phenotype 
would be a reduction in vSMCs in proximal vessels, as well as a reduction in the distal 
capillaries. Figure modified from Udan et al., 2013a. 
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Figure 2. Hypothesis 2: Hemodynamic force promotes the recruitment of vSMCs. In 
normal-flow yolk sacs, vSMCs are capable of differentiating evenly throughout the entire 
yolk sac. However, proximal vessels with higher hemodynamic force promote the 
recruitment of vSMCs from distal capillaries with lower hemodynamic force. If 
hemodynamic force is reduced throughout the entire yolk sac, there will be an absence of 
recruitment signals, but there will be no change in the overall amount of vSMCs 
available. Thus, the expected phenotype would be the appearance of a greater amount of 
unbound vSMCs (vSMCs that fail to recruit and surround vessels) in distal capillary 
regions. Figure modified from Udan et al., 2013a. 
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Figure 3. Proximal arteries exhibit greater vSMC coverage than proximal veins and distal 
capillaries. Whole mount embryonic mouse yolk sacs were labeled with endothelial cell 
(Kdr/Flk1:Alexa Fluor488) and vSMC cell (Sma-myr::mCherry) markers to display the 
proximal artery, proximal vein, and distal capillaries in a normal-flow yolk sac. The 
artery shows complete vSMC coverage around the vessel, which is comprised on 
endothelial cells (A-C). In comparison, the vein shows vSMC coverage around the 
vessel, however, vSMC coverage is sparse when compared to the artery (D-F). The 
capillary region of the yolk sac (G-I) shows the most significant reduced coverage, as 
only individual vSMCs are found around the endothelium. 
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Figure 4. Vascular smooth muscle layer is reduced in low hemodynamic force. 
Embryonic whole mount yolk sac and dorsal aorta cross section tissue were labeled with 
endothelial cell (Kdr/Flk1:Alexa Fluor488) and vSMC cell (Sma-myr::mCherry) 
markers. vSMC coverage is reduced in Myl7 (-/-) reduced-flow proximal arteries (D-F) 
when compared to Myl7 (+/-) normal-flow proximal arteries (A-C). This was also 
observed in intraembryonic tissues, as the cross sections of the dorsal aorta of normal-
flow embryos displayed high vSMC coverage (G-I); whereas, the dorsal aorta of reduced-
flow embryos exhibited diminished/absent vSMC coverage (J-L). 
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Figure 5. Low hemodynamic force does not impact the proliferation and differentiation of 
vSMCs. Representative images of E10.5 Myl7 wild-type (normal-flow) yolk sacs (A-D) 
and Myl7 mutant (reduced-flow) yolk sacs (E-H). Yolk sacs were labeled with phosho-
histone H3 (PH3) and Alexa Fluor488 antibodies (mitotic marker) and Sma-
myr::mCherry (Sma) smooth muscle marker. The total number of PH3, Sma double 
positive cells were divided by the total surface area occupied by Sma-labeled cells to 
develop the mitotic index. Comparison of the mitotic index between the normal-flow and 
reduced-flow yolk sacs reveal no significant difference (I). Statistical significance was 
calculated using standard error, p <0.05. 
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Figure 6. Total number of vSMCs is not impacted by low hemodynamic force. Flow 
cytometry analysis, using the Sma-myr::mCherry smooth muscle marker to label vSMCs, 
revealed that the total number of vSMCs is not significantly different between normal-
flow or reduced-flow embryonic or yolk sac tissue. Statistical significance was calculated 
using standard error, p <0.05. 
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Figure 7. Recruitment of vSMCs from capillary region is impaired in low hemodynamic 
force yolk sacs. Representative images of distal capillary regions of Myl7 wild-type 
(normal-flow) yolk sacs (A-D) and Myl7 mutant (reduced-flow) yolk sacs (E-H). Yolk 
sacs were labeled with Kdr/Flk1:Alexa Fluor488 endothelial marker and Sma-
myr::mCherry smooth muscle marker. Myl7 mutant yolk sacs displayed significantly 
(P<0.001) increased vSMC area coverage when compared to Myl7 wild-type capillary 
regions (I). 
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